Secondary prevention for lung cancer involves screening methods that aim to detect the disease in its early stages, before ...

Oncologists want definitive guidance on whether patients with resectable NSCLC benefit from immunotherapy before and after ...

Lung cancer, long known to affect smokers, is seeing a significant rise in people who do not smoke, said doctors, raising ...

Lung cancer, long known to affect smokers, is seeing a significant rise in people who do not smoke, said doctors on Monday ...

The National Health Insurance (NHI) cannot provide the best care for people with lung cancer despite government goals to ...

AstraZeneca Plc’s drug Tagrisso won clearance in the European Union for an advanced form of non-small cell lung cancer, extending the revenue potential for the drugmaker’s top-selling cancer medicine.

Over a 45-years span — between 1975 and 2020 — improvements in cancer screenings and prevention strategies have reduced ...

(Alliance News) - AstraZeneca PLC on Monday said it has received approval in the European Union for Tagrisso, its non-small cell lung cancer treatment.

Lung cancer is one of the most common and deadly cancers that occurs due to poor lung health. However, early symptoms can lead to treatment that makes a big difference. Discover the various symptoms ...

Audrey Park had a 13-hour-surgery to remove her left kidney and cancerous tumor. She is now undergoing 42 weeks of ...

Lord Henry Mountcharles has revealed how he still struggles with living with lung cancer after the disease left him fighting ...

Pre-operative fractionated stereotactic radiotherapy (FSRT) “compares favorably” to post-operative FSRT, according to researchers.